These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28488914)

  • 1. Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.
    Niscola P; Abruzzese E; Trawinska MM; Palombi M; Tendas A; Giovannini M; Scaramucci L; Cupelli L; Fratoni S; Noguera NI; Catalano G; de Fabritiis P
    Acta Oncol; 2017 Oct; 56(10):1331-1333. PubMed ID: 28488914
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Oka S; Ono K; Nohgawa M
    Ann Hematol; 2017 Aug; 96(8):1411-1413. PubMed ID: 28577044
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the
    Wang F; Chen Y; Jiang N; Gong S; Cao T; Yuan J; Liu J; Xie L; Wu Y; Jia Y
    Leuk Lymphoma; 2019 Dec; 60(13):3304-3307. PubMed ID: 31256701
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
    Abruzzese E; Trawinska MM; Neri B; Bondanini F; Fratoni S; Tendas A; Scaramucci L; Siniscalchi A; Giovannini M; Palumbo R; de Fabritiis P; Niscola P
    Acta Haematol; 2018; 140(4):231-233. PubMed ID: 30384359
    [No Abstract]   [Full Text] [Related]  

  • 5. Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia.
    Niscola P; Neri B; Catalano G; Morino L; Giovannini M; Scaramucci L; Fratoni S; Noguera NI; Cordone I; de Fabritiis P
    Acta Oncol; 2017 Aug; 56(8):1120-1121. PubMed ID: 28406054
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Niscola P; Neri B; Morino L; de Fabritiis P
    Acta Haematol; 2018; 139(1):58-59. PubMed ID: 29402783
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes.
    Bohl SR; Dolnik A; Jensen T; Lang KM; Hackanson B; Gaidzik VI; Paschka P; Knudsen S; Döhner K; Döhner H; Claus R; Lübbert M; Bullinger L
    Leuk Lymphoma; 2017 Sep; 58(9):1-4. PubMed ID: 28278722
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemic transformation in essential thrombocythemia.
    Bhatt VR
    Future Oncol; 2014 Dec; 10(16):2593-602. PubMed ID: 25531047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decitabine-cedazuridine as first line in acute myeloid leukaemia ineligible for conventional induction chemotherapy].
    Tauveron-Jalenques U; Lambert J
    Bull Cancer; 2024 May; 111(5):435-436. PubMed ID: 38582741
    [No Abstract]   [Full Text] [Related]  

  • 10. Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts.
    Kadia TM; Thomas XG; Dmoszynska A; Wierzbowska A; Minden M; Arthur C; Delaunay J; Ravandi F; Kantarjian H
    Am J Hematol; 2015 Jul; 90(7):E139-41. PubMed ID: 25858582
    [No Abstract]   [Full Text] [Related]  

  • 11. [5-day decitabine for treatment of myelodysplastic syndromes with complex karyotype abnormalities and acute myeloid leukemia].
    Gao S; Hu XH; Qiu HY; Xu Y; Jin ZM; He GS; Tang XW; Han Y; Chen SN; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):542-3. PubMed ID: 23827117
    [No Abstract]   [Full Text] [Related]  

  • 12. [An acute leukemia case with complex karyotype abnormalities and marked thrombocythemia].
    Okamura T; Hayakawa H; Sumida I; Hanada M; Nakasato S; Takeshita M; Ohgami A; Kikuchi M; Kamada N
    Rinsho Ketsueki; 1987 Nov; 28(11):2023-8. PubMed ID: 3482113
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
    Khan N; Hantel A; Knoebel RW; Artz A; Larson RA; Godley LA; Thirman MJ; Liu H; Churpek JE; King D; Odenike O; Stock W
    Leuk Lymphoma; 2017 Sep; 58(9):1-7. PubMed ID: 28278716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
    Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
    Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
    Nieto M; Demolis P; Béhanzin E; Moreau A; Hudson I; Flores B; Stemplewski H; Salmonson T; Gisselbrecht C; Bowen D; Pignatti F
    Oncologist; 2016 Jun; 21(6):692-700. PubMed ID: 27091416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient.
    Hsiao HH; Yang WC; Liu YC; Lee CP; Lin SF
    Leuk Res; 2008 Aug; 32(8):1323-4. PubMed ID: 18078991
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
    Björkholm M; Hultcrantz M; Derolf ÅR
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):141-53. PubMed ID: 25189725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
    Suleiman Y; Dalia S; Liu JJ; Bowers JW; Padron E; Lancet JE; Fulp W; Moscinski LC; Komrokji RS; Zuckerman KS; Zhang L
    Leuk Res; 2016 Mar; 42():52-8. PubMed ID: 26894965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of decitabine in the treatment of myeloid sarcoma.
    Gornicec M; Wölfler A; Stanzel S; Sill H; Zebisch A
    Ann Hematol; 2017 Mar; 96(3):505-506. PubMed ID: 27817041
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis.
    He PF; Zhou JD; Yao DM; Ma JC; Wen XM; Zhang ZH; Lian XY; Xu ZJ; Qian J; Lin J
    Oncotarget; 2017 Jun; 8(25):41498-41507. PubMed ID: 28489568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.